Iovance Biotherapeutics Inc. buy The Goldman Sachs Group, Inc.
Start price
20.02.24
/
50%
€11.80
Target price
20.02.25
€17.55
Performance (%)
-20.19%
Price
13:08
€9.42
Summary
This prediction is currently active. The price of Iovance Biotherapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -20.19%. This prediction currently runs until 20.02.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Iovance Biotherapeutics Inc. | -2.727% | -2.727% |
iShares Core DAX® | -1.347% | 3.576% |
iShares Nasdaq 100 | 1.169% | 7.020% |
iShares Nikkei 225® | -0.327% | -0.673% |
iShares S&P 500 | 0.510% | 4.445% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $13.00 to $19.00. They now have a "buy" rating on the stock.
Ratings data for IOVA provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€14.52
29.02.24
29.02.24
€19.38
28.02.25
28.02.25
-35.14%
13:08
13:08
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€5.05
20.11.23
20.11.23
€10.98
20.11.24
20.11.24
86.50%
13:08
13:08